ClinicalTrials HQ

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Active, not recruiting · NCT02955940 · Registry updated 2026-08-17
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast cancer, breast disorder, breast neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, lung cancer, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorderActive, not recruitingPhase 22026-08-17NCT02955940

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Incyte Corporation153

9 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Instytut Hematologii i TransfuzjologiiWarsawPoland21
New York Oncology Hematology Pc.Clifton ParkUnited States1
Renovatio Clinical Consultants LlcThe WoodlandsUnited States1
Samodzielny Publiczny Szpital KlinicznyLublinPoland1
Sp Zoz Szpital Uniwersytecki W Krakowie Oddzial Kliniczny HematologiiKrakowPoland1
Tennessee OncologyNashvilleUnited States77
UCLA Healthcare Hematology-OncologySanta MonicaUnited States3
University of LouisvilleLouisvilleUnited States83
University of Texas M. D. Anderson Cancer CenterHoustonUnited States6